Popular Blood Pressure Meds Not Linked to Cancer, FDA Says
U.S. health authorities complete safety review, exonerate angiotensin-receptor blockersContinue Reading
U.S. health authorities complete safety review, exonerate angiotensin-receptor blockersContinue Reading
Hypertension tends to be more severe in people with the skin condition, study findsContinue Reading
Patients with pulmonary arterial hypertension don’t benefit from aspirin or simvastatin, study findsContinue Reading
Study finds that high levels indicate drug treatment is workingContinue Reading
Activities that raise blood pressure appear to be the cause, researcher suggestsContinue Reading
But, European researchers acknowledge younger, white volunteers may have skewed resultsContinue Reading
Formula vs. breast-fed babies show metabolic differences in first three years of lifeContinue Reading
Counters previous research that found a benefit, but authors say more study neededContinue Reading
But they’re still at raised risk over those without hypertensionContinue Reading
Common reasons for hypotensionContinue Reading
Readings vary throughout day, typically lowest in morning, researchers findContinue Reading
VA has made improvements, but more needs to be done, study saysContinue Reading
Study found ARB, calcium channel blocker both helped those with hypertension, glucose intoleranceContinue Reading
Electrical jolt tricks body into regulating blood pressure, researchers sayContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.